Publications database

Drug-checking services provide individuals who use drugs with information on the chemical content of their drugs as well as advice and, sometimes, counselling or brief interventions. Service priorities vary and may include information collection, harm reduction and early warning. The analytical...

Benzodiazepines are a widely prescribed group of medicines used to treat anxiety and insomnia and to manage alcohol withdrawal. A growing number of benzodiazepines which are not approved medicines within the European Union, such as flubromazolam or flubromazepam, have been sold at street level and...

The co-occurrence of substance use disorders with other mental health conditions (dual disorders) is very common, and these patients typically have more severe problems – clinically and psychosocially – than patients with only substance use disorders. This spotlight outlines key issues related to...

Links between sexual health and drug problems can arise in a number of ways, yet in Europe, treatment services for drug and sexual health problems are usually funded separately, have different eligibility criteria and are rarely co-located. This spotlight outlines key issues related to sexual...

Performance- and image-enhancing drugs (PIEDs) are substances used to improve or change a person’s physical appearance, and/or increase their strength and sporting prowess. PIEDs form part of a wider category of substances, often referred to as human enhancement drugs (HEDs). This spotlight...